Autoimmune Disorders

Welcome and overview of Karolinska Institutet’s program and Mayo Clinic collaborative projects: Rheumatologic emphasis (10 min)

- Chairs

The metabolic signature of pro-inflammatory macrophages in rheumatoid arthritis (15 min)

- Dr Tuantuan Zhao, MC

Neuroimaging biomarkers differ between patients with and without rheumatoid arthritis: results (15 min)

- Dr. Elena Myasoedova, MC

Characterization of humanized mice expressing auto-reactive T cell receptor (TCR) sequences isolated from rheumatoid arthritis patients (15 min)

- Dr. Bruno Raposo, KI

Persistence to methotrexate treatment in early rheumatoid arthritis has a familial component (15 min)

- MSc. Anton Öberg Sysojev, KI

T cells in early RA synovia are predominantly CD4+ with a broad repertoire (15 min)

- MD Sara Turcinov, KI

HLA-DRB1 associations with autoantibody-based clusters in idiopathic inflammatory myopathies (15 min)

- Dr. Valérie Leclair, KI

Autoantigenic properties for the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies (15 min)

- Dr. Antonella Notarnicola, KI

 High urinary and renal expression of IL-16 in lupus nephritis (15 min)

- Dr. Vilija Oke, KI

The impact of remission and low disease activity attainment on health-related quality of life in two phase III clinical trials of Belimumab in SLE (15 min)

- Shahrzad Kia Komujuni, KI

No evidence of rebound MS disease activity with presence of CD20+ T cells at B-cell reconstitution after treatment with rituximab (15 min)

- Dr. Nicolas Ruffin, KI

Early changes in circulating B-cell subsets as markers of clinical improvement or flare during belimumab therapy in SLE (15 min)

- Dr. Ioannis Parodis, KI

Small Intestinal axis for treating inflammatory diseases (15 min)

- Dr. Veena Taneja, MC

Diagnostic Value of Aquaporin-4-IgG Live Cell Based Assay in Neuromyelitis Optica Spectrum (15 min)

- Dr. Vyanka Redenbaugh, MC

Lifestyle-related risk factors for sarcoidosis: a nested case-control study (15 min)

- MSc. Marina Dehara, KI

Discussions and concluding remarks (5 min)